X

Hematology Advisor

Hematology Advisor
Extracorporeal Photopheresis in Pediatric Chronic Graft vs Host Disease

ECP is a safe treatment approach for kids who have steroid-refractory cGVHD, while enabling high response rates but with further immunosuppressive treatment required for some patients.

Hematology Advisor
10/20/2021
Genomic Markers May Predict Clinical Outcomes in Patients With B-Cell Acute Lymphoblastic Leukemia

Among adult patients with BCRABL1 negative B-ALL, genomic evaluation may lead to improved risk assessment, according to research published in Blood.

Hematology Advisor
10/20/2021
Cell-Free DNA Blood Test Shows Promise as Assessment to Screen for Lung Cancer

Scientists develop a genome-wide approach to analyze cfDNA “fragmentomes” to increase sensitivity of detection of early-stage cancers.

Hematology Advisor
10/14/2021
Salvage Autologous Stem Cell Transplantation May Improve Outcomes for Relapsed/Refractory Multiple Myeloma

Salvage therapy with high-dose chemotherapy followed by ASCT may lead to long-term improvements in survival for MM in some patients.

Hematology Advisor
10/12/2021
Polatuzumab Vedotin May Be Effective Salvage or Bridging Therapy for Large B-Cell Lymphomas

Polatuzumab vedotin may be an effective for patients with R/R large B-cell lymphoma as a bridging therapy to CAR T-cell therapy.

Hematology Advisor
10/07/2021
Safety of a Bispecific Antibody in Relapsed/Refractory Acute Myeloid Leukemia and Myelodysplastic Syndrome

Researchers aimed to determine the safety and tolerability of APVO436 in patients with R/R AML or MDS and to identify a recommended phase 2 dose (RP2D) level.

Hematology Advisor
09/28/2021
Safety of a Bispecific Antibody in Relapsed/Refractory Acute Myeloid Leukemia and Myelodysplastic Syndrome

Investigators aimed to determine the safety and tolerability of APVO436 in patients with R/R AML or MDS and to identify a recommended phase 2 dose (RP2D) level. 

Hematology Advisor
09/28/2021
Effectiveness of Corticosteroids in the Treatment of Chemotherapy-Induced Thrombocytopenia

According to study results presented during ESMO Congress 2021, corticosteroids appeared to have a benefit in the treatment of mild to moderate CT-induced thrombocytopenia...

Hematology Advisor
09/20/2021
Patients With Cancer and COVID-19 Face Increased Risk of Thromboembolic Events

Among patients with cancer, COVID-19 infection may lead to life-threatening thromboembolic events even after acute illness, necessitating risk prediction tools for TEs.

Hematology Advisor
09/18/2021
R-NPLD Combination Treatment Safe and Effective for Patients With DLBCL

R-NPLD is an effective and safe combination in patients aged 80 years or older with DLBCL, according to study results presented at the ESMO Congress 2021.

Hematology Advisor
09/18/2021
Subscribe to Hematology Advisor

source list reference

rgb(171, 222, 222)
#7d60d9
#2694a4
#32a887
200, 66, 245
#85eb24
rgb(195, 2, 230)
#352625
#4d4537
rgb(209, 15, 15)
rgb(115, 43, 196)
rgb(9, 151, 227)
#d2093c
#8e3f1c
rgb(242, 0, 137)
#76b6c3
rgb(48, 38, 189)
rgb(231, 165, 240)
rgb(230, 21, 49)
#bfcfc8
#c61417
rgb(156, 242, 7)
#67e25b
#efef71
#03cffc
rgb(224, 4, 129)
#42fc9a
rgb(80, 147, 199)
#cc529a
#c59445
#c8cc0c
#bf6be3
#e8085a
#97d1a0
#74e391
#eb6342
#b61f77
#a153ac
rgb(5, 235, 235)
#e7f6e3
#6fc969
#9a8c2c
#a9c507
rgb(235, 190, 9)
#2b9ab3
#e61923
rgb(209, 227, 11)
#990677
#4a7bab
200, 66, 245
#89f67c
#49a21d
#2c990a
#d7da81
#f5ce42
rgb(217, 7, 192)
#575662
#a60538
rgb(2, 230, 230)
#49cde9
#c20fce
rgb(80,199,199)
#d95d39
#eb5834